制剂新剂型新技术在灯盏花素研究中的应用进展  

Progress in research of new breviscapine dose forms and their new preparation techniques

作　　者：崔亚男[1] 管华[1] 张强[2] 

机构地区：[1]济宁医学院药学院,日照276826 [2]北京大学医学部药学院,北京100191

出　　处：《中国新药杂志》2013年第18期2152-2158,共7页Chinese Journal of New Drugs

基　　金：山东省教育厅国内访问学者资助项目(2012-2013)

摘　　要：目的:总结制剂新技术、新剂型在灯盏花素研究中的应用进展,为合理开发灯盏花素新制剂提供参考,并为中药制剂的现代化建设提供建议。方法:通过查阅近20年的相关文献,对所报道的灯盏花素制剂进行分类、概括和总结。结果:近年来有大量文献对灯盏花素制剂进行了报道,应用的制剂技术亦多样化。结论:关于灯盏花素的研究已成为中药研发的热点。但真正上市的药物品种很少,大家的研究具有扎堆现象,这也一定程度上反映了国内在创新中药的研制方面具有一定的局限性。Objective ： To summarize progress in the research of new breviscapine dose forms and their new preparation techniques, providing references for reasonable development of new breviscapine formulations as well as modernization of traditional Chinese medicine. Methods： The literature of breviscapine published in last 20 years was searched, and the breviseapine dose forms were classified and summarized. Results： Breviscapine preparations were reported in a great deal of articles, and multiple preparation techniques were also reported. Conclusion： The study of breviseapine has been one of the research hotspots in traditional Chinese medicine, but there are still less preparations in the market. The clustering in breviscapine research reflects the limitations of researches in the tradi- tional Chinese medicine.

关 键 词：灯盏花素 制剂新技术 中药 

分 类 号：R943[医药卫生—药剂学]